TY - JOUR T1 - Plasma lipidomic profiles and risk of diabetes: two prospective cohorts of HIV-infected and HIV-uninfected individuals JF - medRxiv DO - 10.1101/2020.11.11.20229351 SP - 2020.11.11.20229351 AU - Eric Zhang AU - Jin Choul Chai AU - Amy A. Deik AU - Simin Hua AU - Anjali Sharma AU - Michael F. Schneider AU - Deborah Gustafson AU - David B. Hanna AU - Jordan E. Lake AU - Leah H. Rubin AU - Wendy S. Post AU - Kathryn Anastos AU - Todd Brown AU - Clary B. Clish AU - Robert C. Kaplan AU - Qibin Qi Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/13/2020.11.11.20229351.abstract N2 - Objectives Antiretroviral therapy (ART) use is associated with disrupted lipid and glucose metabolism in people with HIV-infection. We aimed to identify plasma lipid species associated with risk of diabetes in the context of HIV infection.Research Design and Methods We profiled 211 plasma lipid species in 491 HIV-infected and 203 HIV-uninfected participants aged 35-55 years from the Women’s Interagency HIV study and the Multicenter AIDS Cohort Study. Cox proportional hazards model was used to examine associations between baseline lipid species and incident diabetes (166 diabetes cases were identified during a median follow-up of 12.6 years).Results We identified 11 lipid species, representing independent signals for 8 lipid classes/subclasses, associated with risk of diabetes (P<0.05 after FDR correction). After adjustment for multiple covariates, cholesteryl ester (CE)(22:4), lysophosphatidylcholine (LPC)(18:2), phosphatidylcholine (PC)(36:4), phosphatidylcholine-plasmalogen(34:3), and phosphatidylethanolamine (PE)(38:2) were associated with decreased risk of diabetes (HRs=0.70 to 0.82 per SD increment), while diacylglycerol(32:0), LPC(14:0), PC(38:3), PE(36:1), and triacylglycerol(50:1) were associated with increased risk of diabetes (HRs=1.26 to 1.56 per SD increment). HIV serostatus did not modify any lipid-diabetes associations; however, most of these lipid species were positively associated with HIV and/or ART use, including 3 diabetes-decreased (CE(22:4), LPC(18:2), PE(38:2)) and all 5 diabetes-increased lipid species.Conclusions This study identified multiple plasma lipid species associated with incident diabetes. Regardless of the directions of their associations with diabetes, most diabetes-associated lipid species were elevated in ART-treated people with HIV-infection. This suggests a complex role of lipids in the link between ART and diabetes in HIV infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe metabolomics profiling was supported by the National Heart, Lung, and Blood Institute (NHLBI) K01HL129892, and other funding sources for this study include NHLBI R01HL140976 and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01DK119268 to Q.Q., NHLBI R01 HL126543, R01 HL132794, R01HL083760 and R01HL095140 to R.C.K., NHLBI R01HL095129 to W.S.P., NHLBI K01HL137557 to D.B.H., and the New York Regional Center for Diabetes Translation Research (P30 DK111022) from the NIDDK.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This metabolomics study was approved by the Institutional Review Board of Albert Einstein College of Medicine (Reference #: 009257).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSome or all datasets generated during and/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request. ER -